0 items USD 0.00Search
Your search for "Country SWOT Analysis" gave back 173 results.
The Competitive Intelligence report about Nonalcoholic Steatohepatitis (NASH) - Novel Drug Candidates provides a competitor analysis in the...
颁补迟补濒辞驳:听
La Merie Publishing
January 2015
Price: USD 249.00
The present Competitive Intelligence Report about Anti-Infective Peptides used to treat bacterial, viral and fungal infections provides a competitor...
颁补迟补濒辞驳:听
La Merie Publishing
November 2014
Price: USD 444.00
The present Competitive Intelligence Report about peptide therapeutics provides a competitor evaluation in the field of marketed and new molecules...
颁补迟补濒辞驳:听
La Merie Publishing
September 2014
Price: USD 317.00
The Competitive Intelligence Report Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists as of August 2014 provides a competitor analysis in the...
颁补迟补濒辞驳:听
La Merie Publishing
August 2014
Price: USD 469.00
The present Competitive Intelligence report about Kallikrein Inhibitors & Bradykinin Receptor Antagonists provides a competitor evaluation in the...
颁补迟补濒辞驳:听
La Merie Publishing
June 2014
Price: USD 136.00
The present Competitive Intelligence Report about phosphodiesterase 4 (PDE-4) Inhibitors provides a competitor evaluation in the field of mainly...
颁补迟补濒辞驳:听
La Merie Publishing
June 2014
Price: USD 272.00
The present Competitive Intelligence Report about alpha1-proteinase inhibitors (alpha1-PI), alpha1-antitrypsin (AAT) and elastase inhibitors provides...
颁补迟补濒辞驳:听
La Merie Publishing
July 2014
Price: USD 272.00
The present Competitive Intelligence report about Cancer Vaccines provides a competitor evaluation in the field of novel prophylactic and therapeutic...
颁补迟补濒辞驳:听
La Merie Publishing
March 2014
Price: USD 1,112.00
The report 鈥淎ntibody Technologies and Attrition Rates 鈥� an industry analysis 2013鈥� is based on the identification of the antibody generation...
颁补迟补濒辞驳:听
La Merie Publishing
March 2013
Price: USD 2,960.00
Biosimilar and Biosuperior Therapeutic Antibodies 2014 The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic...
颁补迟补濒辞驳:听
La Merie Publishing
March 2014
Price: USD 1,514.00
EGF-R Antibodies 鈥揃iosimilars and Biosuperiors The present Competitive Intelligence Report about EGF-R Antibodies 鈥揃iosimilars and Biosuperiors...
颁补迟补濒辞驳:听
La Merie Publishing
March 2014
Price: USD 344.00
The present Competitive Intelligence Report about Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors provides a competitor...
颁补迟补濒辞驳:听
La Merie Publishing
February 2014
Price: USD 413.00
TNF Antibodies 鈥揃iosimilars and Biosuperiors The present Competitive Intelligence Report about TNF Antibodies 鈥揃iosimilars and Biosuperiors provides...
颁补迟补濒辞驳:听
La Merie Publishing
March 2014
Price: USD 551.00
Novel Prophylactic and Therapeutic Approaches to Manage and Prevent Clostridium difficile Infections (CDI) Clostridium difficile infections (CDI) are...
颁补迟补濒辞驳:听
La Merie Publishing
January 2014
Price: USD 267.00
VEGF Antibodies 鈥� Bevacizumab and Ranibizumab Biosimilars and Biosuperiors The present Competitive Intelligence Report about VEGF Antibodies 鈥�...
颁补迟补濒辞驳:听
La Merie Publishing
February 2014
Price: USD 401.00
听
